Loading

The Uromigos

The Uromigos, Thomas Powles, MD, and Brian Rini, MD, FASCO, highlight the latest developments in genitourinary cancers. Each podcast episode features a guest expert from around the world discussing the latest data, debates, and manuscripts relevant to the practical clinical care of GU oncology patients.

ASCO
image header

Get exclusive coverage of The Uromigos Live & Unplugged in Nashville, Tennessee, September 30 through October 1, including access to 3 livestream panel discussions.

Advertisement

Latest Episode

The Uromigos Episode 189: Paper of the Month—Robotic Versus Open Cystectomy

John Kelly, MD, FRCS, joins The Uromigos to give an overview of a recent paper published in JAMA, “Effect of Robot-Assisted Radical Cystectomy With Intracorporeal Urinary Diversion vs Open Radical Cystectomy on 90-Day Morbidity and Mortality Among Patients With Bladder Cancer: A Randomized Clinical Trial.” The paper describes the benefits of robotic surgery compared with open cystectomy. ...

Advertisement

ESMO Coverage

Paper of the Month

Dr. Brian Rini’s Disclosures

Research Funding to Institution: Pfizer, Hoffman-LaRoche, Incyte, AstraZeneca, Taris, Seattle Genetics, Arrowhead Pharmaceuticals, Immunomedics, BMS, Mirati Therapeutics, Merck, Surface Oncology, Dragonfly Therapeutics, Aravive, Exelixis

Consulting: BMS, Pfizer, GNE/Roche, Aveo, Synthorx, Compugen, Merck, Corvus, Surface Oncology, 3DMedicines, Aravive, Alkermes, Arrowhead, GSK, Shionogi, Eisai

Stock: PTC therapeutics

Advertisement
Advertisement